Guggenheim Capital LLC Sells 2,675 Shares of Cigna Group $CI

Key Points

• Guggenheim Capital LLC has reduced its stake in Cigna Group by 7.2%, holding 34,261 shares valued at approximately $11.27 million.
• Cigna Group reported $7.20 EPS for the last quarter, surpassing analysts' expectations, with quarterly revenue rising by 11% year-over-year.
• The company announced a quarterly dividend of $1.51 per share, equating to a 2.0% yield, payable on September 18th.

Guggenheim Capital LLC lessened its holdings in Cigna Group (NYSE:CI - Free Report) by 7.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 34,261 shares of the health services provider's stock after selling 2,675 shares during the quarter. Guggenheim Capital LLC's holdings in Cigna Group were worth $11,272,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in the business. Price T Rowe Associates Inc. MD boosted its holdings in Cigna Group by 10.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider's stock valued at $3,966,690,000 after purchasing an additional 1,094,327 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its stake in shares of Cigna Group by 0.9% during the 1st quarter. Massachusetts Financial Services Co. MA now owns 11,654,993 shares of the health services provider's stock worth $3,834,493,000 after acquiring an additional 98,715 shares in the last quarter. Dodge & Cox boosted its stake in shares of Cigna Group by 1.3% during the 1st quarter. Dodge & Cox now owns 8,889,733 shares of the health services provider's stock worth $2,924,722,000 after acquiring an additional 117,125 shares in the last quarter. GQG Partners LLC boosted its stake in shares of Cigna Group by 21.5% during the 1st quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider's stock worth $1,607,716,000 after acquiring an additional 865,092 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Cigna Group by 15.1% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,495,592 shares of the health services provider's stock worth $689,133,000 after acquiring an additional 326,633 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company's stock.

Wall Street Analyst Weigh In

CI has been the topic of several research analyst reports. Cowen reissued a "buy" rating on shares of Cigna Group in a research note on Monday, May 5th. Cantor Fitzgerald restated an "overweight" rating and set a $365.00 price objective on shares of Cigna Group in a research report on Tuesday, August 26th. Royal Bank Of Canada restated an "outperform" rating and set a $371.00 price objective on shares of Cigna Group in a research report on Thursday, June 26th. Deutsche Bank Aktiengesellschaft set a $415.00 price objective on Cigna Group and gave the stock a "buy" rating in a research report on Tuesday, August 5th. Finally, Robert W. Baird set a $372.00 price objective on Cigna Group in a research report on Thursday, August 14th. Two analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Buy" and a consensus price target of $374.82.

Insider Buying and Selling at Cigna Group

In related news, insider Nicole S. Jones sold 28,526 shares of the stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the sale, the insider owned 25,648 shares in the company, valued at $7,694,400. This trade represents a 52.66% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 0.70% of the company's stock.

Cigna Group Stock Performance

Shares of CI traded up $1.79 on Tuesday, reaching $302.66. 511,999 shares of the stock traded hands, compared to its average volume of 1,832,215. The firm has a market cap of $80.79 billion, a price-to-earnings ratio of 16.50, a P/E/G ratio of 0.88 and a beta of 0.48. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. Cigna Group has a 12 month low of $256.89 and a 12 month high of $370.83. The stock's 50-day moving average price is $299.24 and its 200-day moving average price is $311.99.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.15 by $0.05. The business had revenue of $67.13 billion for the quarter, compared to analysts' expectations of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.Cigna Group's quarterly revenue was up 11.0% on a year-over-year basis. During the same period in the previous year, the business posted $6.72 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th will be paid a $1.51 dividend. This represents a $6.04 annualized dividend and a dividend yield of 2.0%. The ex-dividend date is Thursday, September 4th. Cigna Group's payout ratio is currently 32.97%.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.